Evolva Holding SA operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Evolva Holding SA with three other
miscellaneous service companies in Europe:
sales of 7.49 million Euro [US$8.22 million]
of which 100%
was Therapeutic Drugs),
(7.75 million Euro [US$8.50 million]
of which 77%
was Immunotherapies), and
C4X Discovery Holdings PLC
based in the United Kingdom
(£7.06 million [US$8.63 million]
Evolva Holding SA reported sales of 8.93 million Swiss Francs (US$8.97 million)
December of 2018.
increase of 30.5%
versus 2017, when the company's sales were 6.85 million Swiss Francs.
Despite this increase, sales are still
below the level achieved in 2016, when Evolva Holding SA
reported sales of 9.58 million Swiss Francs.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Evolva Holding SA had sales
of 8.71 million Swiss Francs.